Skip to content
← Full study record

NCT02958969 · MORE INFO

Limitations, agreements, and source contact

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma · Source last updated 2019-12-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The study is limited by small sample size. The study included 10 patients receiving IMiD monotherapy for maintenance which are patients at lowest risk for VTE due to the absence of dexamethasone and low disease burden.
point Of Contact
email
gpiazza@bwh.harvard.edu
organization
BWH
phone
6177326984
title
Gregory Piazza
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
The study is limited by small sample size. The study included 10 patients receiving IMiD monotherapy for maintenance which are patients at lowest risk for VTE due to the absence of dexamethasone and low disease burden.
point Of Contact
email
gpiazza@bwh.harvard.edu
organization
BWH
phone
6177326984
title
Gregory Piazza

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice